DNA modifications in the evolution of hematopoietic neoplasms (A01)
DNA modifications in the evolution of hematopoietic neoplasms (A01)
批准号:
290281113
负责人:
金额:
$0.0万
依托单位国家:
德国
项目类别:
Collaborative Research Centres
财政年份:
2016
资助国家:
德国
项目状态:
已结题
起止时间:
2015-12-31 至 2019-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The aim of the project is to study the role and regulation of changes in DNA modifications and gene expression, using long-term in vitro cultured patient derived xenograft acute myeloid leukemia cells with and without selective pressure. We plan to look at genome-wide changes and at the conservation, variation and variance of patterns as a function of specific mutations in epigenetic modifiers (DNMT3A, TET2 and IDH1/2) and oncometabolite levels (2HG). The overall aim is to identify and counter epigenetic mechanisms that affect the response or resistance to therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
蛋白精氨酸甲基化转移酶PRMT5调控PPARG促进巨噬细胞M2极化及其在肿瘤中作用的机制研究
-
批准号:82371738
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:郑英霞
-
依托单位: